Noumi Limited (AU:NOU)
ASX:NOU
Top Page
Noumi Limited
(Sydney:NOU)
Select Model
Select Model
Rating:40Underperform
Price Target:
AU$0.11
▼(-16.15% Downside)
Action:DowngradedDate:11/01/25
Noumi Limited's overall stock score is primarily impacted by its weak financial performance and valuation. The company's high leverage and negative equity pose significant risks, while the negative P/E ratio reflects ongoing profitability challenges. Technical indicators suggest a bearish trend, further weighing on the stock's outlook.
Positive Factors
Diversified revenue streams
Noumi’s dual business model — branded consumer products plus contract/private-label manufacturing — provides structural diversification. Contract manufacturing can deliver steady utilisation and base revenue, while branded growth offers upside and margin expansion if distribution and adoption continue.
Negative Factors
Persistent net losses
A sustained negative net margin (‑25.18%) and weakening EBITDA margin point to structural profitability challenges. Continued losses erode equity and limit reinvestment capacity, forcing reliance on external financing or cost cuts that can constrain long‑term growth and strategic flexibility.
Read all positive and negative factors
Positive Factors
Negative Factors
Diversified revenue streams
Noumi’s dual business model — branded consumer products plus contract/private-label manufacturing — provides structural diversification. Contract manufacturing can deliver steady utilisation and base revenue, while branded growth offers upside and margin expansion if distribution and adoption continue.
Read all positive factors
Noumi Limited (NOU) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$30.48M
Dividend YieldN/A
Average Volume (3M)58.99K
Price to Earnings (P/E)―
Beta (1Y)0.62
Revenue Growth1.03%
EPS Growth-52.56%
CountryAU
Employees500
SectorConsumer Defensive
Sector Strength42
IndustryPackaged Foods
Share Statistics
EPS (TTM)-0.09
Shares Outstanding277,109,300
10 Day Avg. Volume37,033
30 Day Avg. Volume58,993
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-0.07
Price to Sales (P/S)0.05
P/FCF Ratio1.15
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$0.18Price Target Upside38.46% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.11
Revenue Forecast (FY)AU$609.10M
Noumi Limited Business Overview & Revenue Model
Company Description
noumi Limited engages in sourcing, manufacture, selling, marketing, and distribution of plant-based beverages, and dairy and nutritional ingredient products to wholesale and consumer markets. It operates in Dairy and Nutritional, and Plant Based B...
How the Company Makes Money
Noumi makes money primarily by selling manufactured food and beverage products through two main routes: (1) branded product sales, where it sells its own branded plant-based milks, dairy beverages, and related nutritional offerings into grocery/re...
Noumi Limited Financial Statement Overview
Summary
Income Statement
45
Neutral
Balance Sheet
30
Negative
Cash Flow
40
Negative
| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 629.25M | 595.84M | 589.79M | 551.56M | 522.34M | 547.29M |
| Gross Profit | 177.34M | 161.72M | 145.75M | 134.77M | 98.42M | 93.53M |
| EBITDA | 49.50M | -132.09M | -61.24M | -6.37M | -122.53M | 28.01M |
| Net Income | -92.14M | -150.00M | -98.33M | -46.91M | -160.74M | -53.18M |
Balance Sheet | ||||||
| Total Assets | 256.32M | 265.17M | 316.20M | 377.95M | 420.13M | 538.67M |
| Cash, Cash Equivalents and Short-Term Investments | 19.30M | 23.18M | 21.57M | 18.56M | 16.21M | 31.67M |
| Total Debt | 744.57M | 614.75M | 533.76M | 491.00M | 455.01M | 462.39M |
| Total Liabilities | 735.71M | 717.51M | 621.14M | 581.49M | 569.14M | 537.18M |
| Stockholders Equity | -479.39M | -452.34M | -304.94M | -203.54M | -149.01M | 1.49M |
Cash Flow | ||||||
| Free Cash Flow | 16.15M | 27.66M | 11.02M | -49.00K | -46.87M | -56.67M |
| Operating Cash Flow | 21.32M | 32.52M | 15.83M | 4.31M | -40.86M | -54.01M |
| Investing Cash Flow | 1.86M | 2.09M | 1.84M | 2.22M | -3.93M | 13.50M |
| Financing Cash Flow | -37.14M | -33.01M | -21.64M | -4.18M | 29.33M | 53.80M |
Noumi Limited Technical Analysis
Neutral
0.13
Price Trends
0.12
Positive
0.12
Negative
0.13
Negative
Market Momentum
<0.01
Negative
51.53
Neutral
100.00
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:NOU, the sentiment is Neutral. The current price of 0.13 is above the 20-day moving average (MA) of 0.12, above the 50-day MA of 0.12, and below the 200-day MA of 0.13, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 51.53 is Neutral, neither overbought nor oversold. The STOCH value of 100.00 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for AU:NOU.
Noumi Limited Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
50 Neutral | AU$28.23M | -2.06 | -41.69% | ― | 102.21% | 69.47% | |
41 Neutral | AU$5.53M | -0.92 | -92.72% | ― | 39.53% | 49.99% | |
40 Underperform | AU$30.48M | -0.37 | 19.78% | ― | 1.03% | -52.56% | |
40 Underperform | AU$26.02M | -5.27 | -19.17% | ― | 13.92% | 36.28% | |
39 Underperform | AU$23.17M | -33.08 | -321.20% | ― | 6.76% | ― |
* Consumer Defensive Sector Average
AU:NOU
Noumi Limited
0.11
-0.03
-21.43%
AU:AHF
Australian Dairy Nutritionals Group
0.03
-0.02
-40.00%
AU:WNX
Wellnex Life Ltd
0.08
-0.40
-83.37%
AU:NUC
Nuchev Pty Ltd
0.18
0.00
0.00%
AU:HCT
Holista Colltech Limited
0.06
0.03
103.23%
Noumi Limited Corporate Events
Noumi Flags Limits of H1 FY26 Results Presentation and Investor Reliance
Feb 23, 2026
Noumi Limited has released a summary presentation of its H1 FY26 results, stressing that the material is general in nature, incomplete, and should not be solely relied upon by investors or other stakeholders. The company emphasises that key financ...
Noumi lifts revenue and EBITDA as Milklab and dairy turnaround underpin H1 FY26
Feb 23, 2026
Noumi Limited reported an 11.2% rise in group revenue to $332.7 million and a 23.3% increase in adjusted operating EBITDA to $33.9 million for the first half of FY26, driven by record sales in Plant-based Milks and a strong turnaround in Dairy Nu...
Noumi narrows half-year loss on revenue growth but faces going-concern risk
Feb 23, 2026
Noumi Limited has reported its half-year results to 31 December 2025, posting an 11.2% rise in revenue to $332.7 million and a 23.3% increase in adjusted operating EBITDA to $33.9 million. Despite this operational improvement, the company remained...
Noumi Sets Date for FY26 Half-Year Results Webcast
Feb 5, 2026
Noumi Limited has scheduled the release of its FY26 half-year results for Tuesday, 24 February 2026, to be delivered via a webcast briefing by Chief Executive Officer Michael Perich and Chief Financial Officer Peter Myers. The online presentation,...
Noumi Boosts Revenue on Export-Led Dairy Growth Despite Q2 Cash Outflow
Jan 30, 2026
Noumi Limited reported a strong second quarter of FY26, with consolidated revenue rising 13.4% year-on-year to $170.3 million, driven by particularly robust growth in the Dairy and Nutritionals division, where revenue climbed 17.7% to $123.0 milli...
Noumi Names Former Lark Distilling Executive as New CFO Amid Ongoing Turnaround
Jan 12, 2026
Noumi Limited has announced that Chief Financial Officer Peter Myers will retire on 1 April 2026 and will be succeeded by Iain Short, former CFO of Lark Distilling Co, following a comprehensive search process. Myers, credited by the board with pla...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.